Monod Bio Launches World’s First Fully De Novo Protein Product: Luciferase LuxSit™ Pro for Life Sciences Research and Diagnostics

– LuxSit™ Pro is the first fully de novo protein to enter the commercial market SEATTLE, July 15, 2024 /PRNewswire/ — Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the launch of…